Nautilus Biotechnolgy
NAUT
NAUT
44 hedge funds and large institutions have $165M invested in Nautilus Biotechnolgy in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
7.88% less ownership
Funds ownership: 85.54% → 77.66% (-7.9%)
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
Holders
44
Holding in Top 10
1
Calls
$393K
Puts
$395K
Top Buyers
| 1 | +$8.39M | |
| 2 | +$5.77M | |
| 3 | +$5.36M | |
| 4 |
PVI
Pura Vida Investments
New York
|
+$4.07M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
+$3.95M |
Top Sellers
| 1 | -$5.81M | |
| 2 | -$5.6M | |
| 3 | -$3.92M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$3.47M |
| 5 |
HP
Hound Partners
New York
|
-$2.96M |